Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No deterioration in insulin sensitivity, but impairment of both pancreatic beta-cell function and glucose sensitivity, in Japanese women with former gestational diabetes mellitus.
Sakamaki H, Yamasaki H, Matsumoto K, Izumino K, Kondo H, Sera Y, Ozaki M, Abe T, Kawasaki E, Takino H, Yamaguchi Y, Eguchi K. Sakamaki H, et al. Among authors: yamasaki h. Diabet Med. 1998 Dec;15(12):1039-44. doi: 10.1002/(SICI)1096-9136(1998120)15:12<1039::AID-DIA710>3.0.CO;2-X. Diabet Med. 1998. PMID: 9868979
Identification and functional analysis of mutations in the hepatocyte nuclear factor-1alpha gene in anti-islet autoantibody-negative Japanese patients with type 1 diabetes.
Kawasaki E, Sera Y, Yamakawa K, Abe T, Ozaki M, Uotani S, Ohtsu N, Takino H, Yamasaki H, Yamaguchi Y, Matsuura N, Eguchi K. Kawasaki E, et al. Among authors: yamasaki h. J Clin Endocrinol Metab. 2000 Jan;85(1):331-5. doi: 10.1210/jcem.85.1.6304. J Clin Endocrinol Metab. 2000. PMID: 10634407 Clinical Trial.
CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
Abe T, Yamaguchi Y, Takino H, Fujita N, Yamauchi-Degawa M, Ozaki M, Yamakawa K, Sera Y, Sakamaki H, Uotani S, Kawasaki E, Awata T, Yamasaki H, Eguchi K. Abe T, et al. Among authors: yamasaki h. Diabet Med. 2001 Sep;18(9):726-31. doi: 10.1046/j.0742-3071.2001.00551.x. Diabet Med. 2001. PMID: 11606170
Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
Takino H, Yamasaki H, Abiru N, Sera Y, Abe T, Kawasaki E, Yamaguchi Y, Eguchi K, Kanazawa Y, Nagataki S. Takino H, et al. Among authors: yamasaki h. Diabet Med. 2002 Sep;19(9):730-4. doi: 10.1046/j.1464-5491.2002.00646.x. Diabet Med. 2002. PMID: 12207808
Islet cell antibodies in patients with autoimmune thyroid disease.
Yamaguchi Y, Chikuba N, Ueda Y, Yamamoto H, Yamasaki H, Nakanishi T, Akazawa S, Nagataki S. Yamaguchi Y, et al. Among authors: yamasaki h. Diabetes. 1991 Mar;40(3):319-22. doi: 10.2337/diab.40.3.319. Diabetes. 1991. PMID: 1999272
Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
Matsumoto K, Akazawa S, Abiru N, Yano M, Ishibasi M, Uotani S, Matsuo H, Kawasaki E, Yamasaki H, Yamamoto H, et al. Matsumoto K, et al. Among authors: yamasaki h. Diabetes Res Clin Pract. 1994 Dec 16;26(2):129-35. doi: 10.1016/0168-8227(94)90150-3. Diabetes Res Clin Pract. 1994. PMID: 7705194 Clinical Trial.
1,264 results